Annual FCF
-$13.45 M
+$6.01 M+30.89%
31 December 2023
Summary:
Windtree Therapeutics annual free cash flow is currently -$13.45 million, with the most recent change of +$6.01 million (+30.89%) on 31 December 2023. During the last 3 years, it has risen by +$12.15 million (+47.47%). WINT annual FCF is now -140.39% below its all-time high of $33.31 million, reached on 31 December 2016.WINT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$2.34 M
+$609.00 K+20.67%
30 June 2024
Summary:
Windtree Therapeutics quarterly free cash flow is currently -$2.34 million, with the most recent change of +$609.00 thousand (+20.67%) on 30 June 2024. Over the past year, it has increased by +$1.53 million (+39.57%). WINT quarterly FCF is now -103.89% below its all-time high of $60.15 million, reached on 31 December 2016.WINT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$12.72 M
+$1.16 M+8.35%
30 June 2024
Summary:
Windtree Therapeutics TTM free cash flow is currently -$12.72 million, with the most recent change of +$1.16 million (+8.35%) on 30 June 2024. Over the past year, it has increased by +$544.00 thousand (+4.10%). WINT TTM FCF is now -128.99% below its all-time high of $43.88 million, reached on 30 September 2017.WINT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
WINT Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +30.9% | +39.6% | +4.1% |
| 3 y3 years | +47.5% | +56.6% | +46.2% |
| 5 y5 years | +14.8% | +37.3% | +50.2% |
WINT Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +47.5% | at high | +65.2% | at high | +48.3% |
| 5 y | 5 years | at high | +47.5% | at high | +71.7% | at high | +52.0% |
| alltime | all time | -140.4% | +77.1% | -103.9% | +91.8% | -129.0% | +80.5% |
Windtree Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$2.34 M(-20.7%) | -$12.72 M(-8.4%) |
| Mar 2024 | - | -$2.95 M(-17.4%) | -$13.88 M(+3.2%) |
| Dec 2023 | -$13.45 M(-30.9%) | -$3.57 M(-7.8%) | -$13.45 M(+1.4%) |
| Sept 2023 | - | -$3.87 M(+10.6%) | -$13.27 M(-1.7%) |
| June 2023 | - | -$3.50 M(+38.8%) | -$13.49 M(-11.6%) |
| Mar 2023 | - | -$2.52 M(-25.5%) | -$15.27 M(-21.6%) |
| Dec 2022 | -$19.46 M(-18.7%) | -$3.38 M(-17.5%) | -$19.46 M(-8.1%) |
| Sept 2022 | - | -$4.10 M(-22.2%) | -$21.19 M(-5.7%) |
| June 2022 | - | -$5.27 M(-21.6%) | -$22.48 M(-8.7%) |
| Mar 2022 | - | -$6.72 M(+31.6%) | -$24.61 M(+2.8%) |
| Dec 2021 | -$23.94 M(-6.5%) | -$5.11 M(-5.2%) | -$23.94 M(+1.3%) |
| Sept 2021 | - | -$5.38 M(-27.3%) | -$23.64 M(-10.9%) |
| June 2021 | - | -$7.41 M(+22.5%) | -$26.53 M(+1.4%) |
| Mar 2021 | - | -$6.05 M(+25.9%) | -$26.17 M(+2.2%) |
| Dec 2020 | -$25.61 M(+3.0%) | -$4.80 M(-41.9%) | -$25.61 M(-2.7%) |
| Sept 2020 | - | -$8.27 M(+17.3%) | -$26.32 M(+20.9%) |
| June 2020 | - | -$7.05 M(+28.6%) | -$21.78 M(+1.3%) |
| Mar 2020 | - | -$5.48 M(-0.7%) | -$21.50 M(-13.5%) |
| Dec 2019 | -$24.85 M(+57.5%) | -$5.52 M(+48.1%) | -$24.85 M(-2.6%) |
| Sept 2019 | - | -$3.73 M(-45.0%) | -$25.52 M(+1.8%) |
| June 2019 | - | -$6.77 M(-23.3%) | -$25.07 M(+13.6%) |
| Mar 2019 | - | -$8.83 M(+42.7%) | -$22.07 M(+39.8%) |
| Dec 2018 | -$15.78 M(-25.1%) | -$6.19 M(+88.9%) | -$15.78 M(+9.6%) |
| Sept 2018 | - | -$3.28 M(-13.0%) | -$14.40 M(-0.7%) |
| June 2018 | - | -$3.77 M(+47.9%) | -$14.50 M(-10.9%) |
| Mar 2018 | - | -$2.55 M(-47.0%) | -$16.26 M(-22.8%) |
| Dec 2017 | -$21.07 M(-163.3%) | -$4.81 M(+42.4%) | -$21.07 M(-148.0%) |
| Sept 2017 | - | -$3.38 M(-39.0%) | $43.88 M(+12.9%) |
| June 2017 | - | -$5.53 M(-24.7%) | $38.88 M(+10.2%) |
| Mar 2017 | - | -$7.35 M(-112.2%) | $35.28 M(+5.9%) |
| Dec 2016 | $33.31 M(-198.1%) | $60.15 M(-818.1%) | $33.31 M(-196.7%) |
| Sept 2016 | - | -$8.38 M(-8.3%) | -$34.43 M(+2.5%) |
| June 2016 | - | -$9.14 M(-2.0%) | -$33.58 M(-1.7%) |
| Mar 2016 | - | -$9.32 M(+22.7%) | -$34.18 M(+0.6%) |
| Dec 2015 | -$33.96 M(-19.0%) | -$7.60 M(+0.9%) | -$33.96 M(-7.1%) |
| Sept 2015 | - | -$7.53 M(-22.6%) | -$36.55 M(-7.8%) |
| June 2015 | - | -$9.73 M(+6.8%) | -$39.65 M(-1.6%) |
| Mar 2015 | - | -$9.11 M(-10.6%) | -$40.28 M(-4.0%) |
| Dec 2014 | -$41.95 M(+2.2%) | -$10.18 M(-4.2%) | -$41.95 M(-0.6%) |
| Sept 2014 | - | -$10.63 M(+2.5%) | -$42.20 M(+1.4%) |
| June 2014 | - | -$10.37 M(-3.8%) | -$41.64 M(+0.4%) |
| Mar 2014 | - | -$10.78 M(+3.2%) | -$41.48 M(+1.0%) |
| Dec 2013 | -$41.06 M(+22.5%) | -$10.44 M(+3.7%) | -$41.06 M(+3.4%) |
| Sept 2013 | - | -$10.06 M(-1.4%) | -$39.73 M(+0.3%) |
| June 2013 | - | -$10.21 M(-1.4%) | -$39.59 M(+3.7%) |
| Mar 2013 | - | -$10.36 M(+13.7%) | -$38.19 M(+13.9%) |
| Dec 2012 | -$33.52 M(+47.0%) | -$9.11 M(-8.3%) | -$33.52 M(+11.9%) |
| Sept 2012 | - | -$9.93 M(+12.7%) | -$29.96 M(+14.7%) |
| June 2012 | - | -$8.80 M(+54.9%) | -$26.12 M(+11.7%) |
| Mar 2012 | - | -$5.68 M(+2.6%) | -$23.39 M(+2.6%) |
| Dec 2011 | -$22.80 M(-6.4%) | -$5.54 M(-9.1%) | -$22.80 M(-0.3%) |
| Sept 2011 | - | -$6.09 M(+0.3%) | -$22.87 M(+5.2%) |
| June 2011 | - | -$6.07 M(+19.2%) | -$21.75 M(-5.5%) |
| Mar 2011 | - | -$5.09 M(-9.1%) | -$23.01 M(-5.6%) |
| Dec 2010 | -$24.37 M(-11.6%) | -$5.61 M(+12.7%) | -$24.37 M(-1.7%) |
| Sept 2010 | - | -$4.97 M(-32.2%) | -$24.80 M(-6.3%) |
| June 2010 | - | -$7.34 M(+13.7%) | -$26.48 M(+0.1%) |
| Mar 2010 | - | -$6.46 M(+6.9%) | -$26.45 M(-4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | -$27.56 M(-14.9%) | -$6.04 M(-9.1%) | -$27.56 M(-6.4%) |
| Sept 2009 | - | -$6.64 M(-9.1%) | -$29.44 M(+2.2%) |
| June 2009 | - | -$7.31 M(-3.5%) | -$28.82 M(-0.2%) |
| Mar 2009 | - | -$7.57 M(-4.4%) | -$28.88 M(-10.8%) |
| Dec 2008 | -$32.38 M(-2.3%) | -$7.92 M(+31.4%) | -$32.38 M(-2.6%) |
| Sept 2008 | - | -$6.02 M(-18.3%) | -$33.26 M(-6.6%) |
| June 2008 | - | -$7.37 M(-33.4%) | -$35.62 M(-2.3%) |
| Mar 2008 | - | -$11.07 M(+26.0%) | -$36.47 M(+10.0%) |
| Dec 2007 | -$33.16 M(-19.7%) | -$8.79 M(+4.8%) | -$33.16 M(+4.4%) |
| Sept 2007 | - | -$8.39 M(+2.0%) | -$31.76 M(+3.9%) |
| June 2007 | - | -$8.22 M(+5.9%) | -$30.58 M(-13.0%) |
| Mar 2007 | - | -$7.76 M(+5.1%) | -$35.16 M(-14.8%) |
| Dec 2006 | -$41.27 M(-29.7%) | -$7.39 M(+2.5%) | -$41.27 M(-33.7%) |
| Sept 2006 | - | -$7.21 M(-43.7%) | -$62.24 M(-4.5%) |
| June 2006 | - | -$12.80 M(-7.8%) | -$65.14 M(+5.7%) |
| Mar 2006 | - | -$13.88 M(-51.0%) | -$61.63 M(+4.9%) |
| Dec 2005 | -$58.73 M(+65.2%) | -$28.36 M(+180.6%) | -$58.73 M(+51.0%) |
| Sept 2005 | - | -$10.11 M(+8.8%) | -$38.90 M(+3.5%) |
| June 2005 | - | -$9.29 M(-15.4%) | -$37.59 M(+0.6%) |
| Mar 2005 | - | -$10.98 M(+28.7%) | -$37.37 M(+5.1%) |
| Dec 2004 | -$35.55 M(+42.3%) | -$8.53 M(-3.0%) | -$35.55 M(-1.0%) |
| Sept 2004 | - | -$8.79 M(-3.1%) | -$35.92 M(+8.4%) |
| June 2004 | - | -$9.07 M(-0.9%) | -$33.13 M(+14.1%) |
| Mar 2004 | - | -$9.15 M(+2.8%) | -$29.04 M(+16.3%) |
| Dec 2003 | -$24.98 M(+80.0%) | -$8.90 M(+48.3%) | -$24.98 M(+25.3%) |
| Sept 2003 | - | -$6.00 M(+20.4%) | -$19.94 M(+11.2%) |
| June 2003 | - | -$4.99 M(-1.9%) | -$17.93 M(+3.9%) |
| Mar 2003 | - | -$5.08 M(+31.5%) | -$17.25 M(+24.3%) |
| Dec 2002 | -$13.87 M(+7.5%) | -$3.86 M(-3.3%) | -$13.87 M(-2.4%) |
| Sept 2002 | - | -$3.99 M(-7.3%) | -$14.21 M(+9.7%) |
| June 2002 | - | -$4.31 M(+152.0%) | -$12.95 M(+12.6%) |
| Mar 2002 | - | -$1.71 M(-59.3%) | -$11.50 M(-10.9%) |
| Dec 2001 | -$12.90 M(+89.6%) | -$4.20 M(+53.3%) | -$12.90 M(+26.2%) |
| Sept 2001 | - | -$2.74 M(-4.0%) | -$10.22 M(+5.5%) |
| June 2001 | - | -$2.85 M(-8.2%) | -$9.69 M(+11.7%) |
| Mar 2001 | - | -$3.11 M(+104.5%) | -$8.67 M(+27.4%) |
| Dec 2000 | -$6.80 M(+60.1%) | -$1.52 M(-31.0%) | -$6.80 M(+27.5%) |
| Sept 2000 | - | -$2.20 M(+19.7%) | -$5.33 M(+17.7%) |
| June 2000 | - | -$1.84 M(+48.1%) | -$4.53 M(+16.4%) |
| Mar 2000 | - | -$1.24 M(+2335.3%) | -$3.89 M(-8.4%) |
| Dec 1999 | -$4.25 M(-39.3%) | -$51.00 K(-96.4%) | -$4.25 M(-26.7%) |
| Sept 1999 | - | -$1.40 M(+16.7%) | -$5.80 M(+1.8%) |
| June 1999 | - | -$1.20 M(-25.0%) | -$5.70 M(-5.0%) |
| Mar 1999 | - | -$1.60 M(0.0%) | -$6.00 M(-14.3%) |
| Dec 1998 | -$7.00 M(+37.3%) | -$1.60 M(+23.1%) | -$7.00 M(-20.5%) |
| Sept 1998 | - | -$1.30 M(-13.3%) | -$8.80 M(+33.3%) |
| June 1998 | - | -$1.50 M(-42.3%) | -$6.60 M(-7.0%) |
| Mar 1998 | - | -$2.60 M(-23.5%) | -$7.10 M(+39.2%) |
| Dec 1997 | -$5.10 M(+131.8%) | -$3.40 M(-477.8%) | -$5.10 M(+112.5%) |
| Sept 1997 | - | $900.00 K(-145.0%) | -$2.40 M(-38.5%) |
| June 1997 | - | -$2.00 M(+233.3%) | -$3.90 M(+62.5%) |
| Mar 1997 | - | -$600.00 K(-14.3%) | -$2.40 M(+9.1%) |
| Dec 1996 | -$2.20 M(-12.0%) | -$700.00 K(+16.7%) | -$2.20 M(+46.7%) |
| Sept 1996 | - | -$600.00 K(+20.0%) | -$1.50 M(+66.7%) |
| June 1996 | - | -$500.00 K(+25.0%) | -$900.00 K(-30.8%) |
| Mar 1996 | - | -$400.00 K(-55.6%) | -$1.30 M(+8.3%) |
| Dec 1995 | -$2.50 M | - | - |
| June 1995 | - | -$900.00 K(+200.0%) | -$1.20 M(+300.0%) |
| Mar 1995 | - | -$300.00 K | -$300.00 K |
FAQ
- What is Windtree Therapeutics annual free cash flow?
- What is the all time high annual FCF for Windtree Therapeutics?
- What is Windtree Therapeutics annual FCF year-on-year change?
- What is Windtree Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Windtree Therapeutics?
- What is Windtree Therapeutics quarterly FCF year-on-year change?
- What is Windtree Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Windtree Therapeutics?
- What is Windtree Therapeutics TTM FCF year-on-year change?
What is Windtree Therapeutics annual free cash flow?
The current annual FCF of WINT is -$13.45 M
What is the all time high annual FCF for Windtree Therapeutics?
Windtree Therapeutics all-time high annual free cash flow is $33.31 M
What is Windtree Therapeutics annual FCF year-on-year change?
Over the past year, WINT annual free cash flow has changed by +$6.01 M (+30.89%)
What is Windtree Therapeutics quarterly free cash flow?
The current quarterly FCF of WINT is -$2.34 M
What is the all time high quarterly FCF for Windtree Therapeutics?
Windtree Therapeutics all-time high quarterly free cash flow is $60.15 M
What is Windtree Therapeutics quarterly FCF year-on-year change?
Over the past year, WINT quarterly free cash flow has changed by +$1.53 M (+39.57%)
What is Windtree Therapeutics TTM free cash flow?
The current TTM FCF of WINT is -$12.72 M
What is the all time high TTM FCF for Windtree Therapeutics?
Windtree Therapeutics all-time high TTM free cash flow is $43.88 M
What is Windtree Therapeutics TTM FCF year-on-year change?
Over the past year, WINT TTM free cash flow has changed by +$544.00 K (+4.10%)